Showing results (61-70 of 1,305) with videos related to
Sort By:
Pageof 131
The Journal of Urology|August 1, 1987
Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancerR B Alexander, J T Isaacs, D S CoffeyThe American Journal of Physiology|June 1, 1986
Effects of aging on prostate growth in beaglesS J Berry, D S Coffey, L L EwingCancer Research|May 1, 1987
Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase IIR B Alexander, W G Nelson, D S CoffeyUrological Survey|February 1, 1978
Current concepts in the study of bladder cancerR M Weissman, D S Coffey, H J JewettThe Prostate|January 1, 1984
The use of multiparameter flow cytometry to assess tumor cell heterogeneity and grade prostate cancerM C Benson, D C McDougal, D S CoffeySteroids|February 1, 1980
The identification and characterization of the C19O3 steroid metabolites of 5 alpha-androstane-3 beta,17 beta-diol produced by the canine prostate: 5 alpha-androstane-3 beta,6 alpha,17 beta-triol and 5 alpha-androstane-3 beta,7 alpha,17 beta-triolJ T Isaacs, I R McDermott, D S CoffeyThe Prostate|January 1, 1992
Effects of extracellular matrix components and dihydrotestosterone on the structure and function of human prostate cancer cellsB C Murphy, K J Pienta, D S CoffeyCancer Research|July 1, 1979
Models for development of nonreceptor methods for distinguishing androgen-sensitive and -insensitive prostatic tumorsJ T Isaacs, W B Isaacs, D S CoffeyFertility and Sterility|February 1, 1975
Preliminary human trial of a new male sterilization procedure: vas sclerosingC FreemanUrology|March 27, 1999
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasiaA M De Marzo, D S Coffey, W G NelsonPageof 131